Issue 000 | U.S. Pilot | US

RKDA

Arcadia Biosciences, Inc.

Passing Verified 10-Q | 2026-05-14 Filing currency: USD
Margin of Safety 44.8%

GNNI internal calculation. Market context inputs are retained internally and are not displayed.

Current Assets
5,169,000USD
Total Liabilities
2,438,000USD
NCAV
2,731,000USD
Cash
954,000USD
NCAV per share
1.33USD/share
Evidence
10 annual | 20 quarterly

Business Profile

Checklist-driven facts extracted from filing text. Missing fields stay visible.

Business profile not generated.

Run python -m application.cli.business_profile run --market US --one RKDA, then regenerate the site.

Known Unknowns

Medium | Share Count

Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric
2025-12-31
10-K
USD
2024-12-31
10-K
USD
2023-12-31
10-K
USD
2022-12-31
10-K
USD
2021-12-31
10-K
USD
2020-12-31
10-K
USD
2019-12-31
10-K
USD
2018-12-31
10-K
USD
2017-12-31
10-K
USD
2016-12-31
10-K
USD
Revenue 4,858,000 5,045,000 5,330,000 9,956,000 6,780,000 8,034,000 1,169,000 1,464,000 4,026,000 3,188,000
Operating Income -2,500,000 -3,648,000 -13,938,000 -18,815,000 -35,526,000 -12,778,000 -19,381,000 -16,870,000 -14,315,000 -18,620,000
Net Income -2,339,000 -7,038,000 -13,981,000 -15,376,000 -14,660,000 -4,655,000 -28,805,000 -13,480,000 -15,707,000 -19,624,000
Cash From Operations -4,739,000 -9,627,000 -15,294,000 -13,977,000 -25,868,000 -30,218,000 -17,198,000 -13,631,000 -13,965,000 -17,055,000
Capex 0 -16,000 -5,000 -72,000 -1,007,000 -2,335,000 -1,477,000 -250,000 -79,000 -231,000
Free Cash Flow -4,739,000 -9,643,000 -15,299,000 -14,049,000 -26,875,000 -32,553,000 -18,675,000 -13,881,000 -14,044,000 -17,286,000
Cash And Equivalents 259,000 4,242,000 6,518,000 20,644,000 28,685,000 14,042,000 8,417,000 11,998,000 9,125,000 2,013,000
Accounts Receivable n/a n/a n/a n/a 1,370,000 1,406,000 602,000 165,000 1,231,000 349,000
Inventory 1,212,000 904,000 1,958,000 2,571,000 4,433,000 3,812,000 1,794,000 181,000 229,000 252,000
Total Current Assets 6,356,000 9,242,000 14,972,000 25,398,000 35,388,000 31,696,000 28,440,000 22,876,000 15,047,000 52,222,000
Total Assets 6,546,000 13,517,000 19,705,000 28,922,000 43,918,000 47,348,000 32,574,000 24,024,000 16,570,000 56,574,000
Total Current Liabilities 2,059,000 2,563,000 3,590,000 4,209,000 5,040,000 6,314,000 5,708,000 3,054,000 3,525,000 3,129,000
Total Liabilities 2,406,000 7,294,000 7,002,000 8,022,000 12,722,000 18,796,000 24,248,000 11,209,000 8,563,000 34,376,000
Shareholders Equity 4,140,000 6,223,000 12,841,000 21,033,000 31,093,000 27,725,000 7,705,000 12,815,000 8,007,000 22,198,000
Shares Outstanding 1,373,120 1,364,940 1,285,337 616,079 22,184,235 13,450,861 8,646,149 4,774,919 2,134,154 44,487,678
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 1,368,057 1,363,303 1,236,934 599,389 532,016 n/a n/a n/a n/a n/a
Weighted Avg Shares Basic 1,368,057 1,363,303 1,236,934 599,389 532,016 n/a n/a n/a n/a n/a
Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Metric
2026-03-31
10-Q
USD
2025-12-31
10-K
USD
2025-09-30
10-Q
USD
2025-06-30
10-Q
USD
2025-03-31
10-Q
USD
2024-12-31
10-K
USD
2024-09-30
10-Q
USD
2024-06-30
10-Q
USD
2024-03-31
10-Q
USD
2023-12-31
10-K
USD
2023-09-30
10-Q
USD
2023-06-30
10-Q
USD
2023-03-31
10-Q
USD
2022-12-31
10-K
USD
2022-09-30
10-Q
USD
2022-06-30
10-Q
USD
2022-03-31
10-Q
USD
2021-12-31
10-K
USD
2021-09-30
10-Q
USD
2021-06-30
10-Q
USD
Revenue 1,100,000 901,000 1,302,000 1,455,000 1,200,000 1,216,000 1,536,000 1,038,000 1,255,000 1,170,000 1,261,000 1,390,000 1,509,000 1,000,000 1,878,000 3,858,000 3,220,000 2,171,000 2,375,000 1,406,000
Operating Income -779,000 -1,377,000 -1,152,000 -501,000 530,000 -804,000 -1,760,000 1,980,000 -3,064,000 -3,364,000 -2,734,000 -3,792,000 -4,048,000 -5,830,000 -4,579,000 -3,783,000 -4,623,000 -13,804,000 -8,713,000 -7,683,000
Net Income -4,385,000 3,122,000 -3,602,000 -4,458,000 2,599,000 -4,064,000 -1,612,000 1,061,000 -2,423,000 -2,853,000 -2,567,000 823,000 -9,384,000 -4,244,000 -2,867,000 -3,777,000 -4,488,000 -4,021,000 -7,436,000 -5,261,000
Cash From Operations -1,099,000 -861,000 -257,000 -2,033,000 -1,588,000 -2,209,000 -1,752,000 -2,456,000 -3,210,000 -4,145,000 -2,885,000 -4,798,000 -3,466,000 -2,356,000 -3,371,000 -3,365,000 -4,885,000 -6,660,000 -8,268,000 -6,233,000
Capex n/a 0 0 0 0 0 0 -3,000 -13,000 0 0 -5,000 0 -26,000 0 -6,000 -40,000 -88,000 -206,000 -228,000
Free Cash Flow n/a -861,000 -257,000 -2,033,000 -1,588,000 -2,209,000 -1,752,000 -2,459,000 -3,223,000 -4,145,000 -2,885,000 -4,803,000 -3,466,000 -2,382,000 -3,371,000 -3,371,000 -4,925,000 -6,748,000 -8,474,000 -6,461,000
Cash And Equivalents 954,000 259,000 1,120,000 1,376,000 3,159,000 4,242,000 3,936,000 5,504,000 3,317,000 6,518,000 10,611,000 13,484,000 22,998,000 20,644,000 22,719,000 21,234,000 24,551,000 28,685,000 35,526,000 43,977,000
Total Current Assets 5,169,000 6,356,000 8,387,000 7,579,000 8,846,000 9,242,000 10,711,000 12,434,000 11,642,000 14,972,000 20,006,000 23,339,000 27,205,000 25,398,000 30,031,000 30,058,000 31,499,000 35,388,000 43,834,000 50,916,000
Total Liabilities 2,438,000 2,406,000 3,141,000 3,255,000 4,085,000 7,294,000 5,092,000 5,803,000 5,563,000 7,002,000 8,068,000 9,068,000 13,718,000 8,022,000 9,455,000 8,240,000 8,557,000 12,722,000 19,005,000 28,119,000
Shares Outstanding 2,056,884 1,373,120 1,367,429 1,367,040 1,367,040 1,364,940 1,364,940 1,362,840 1,362,840 1,285,337 1,110,337 1,108,432 857,572 616,079 24,642,960 22,188,918 22,188,918 22,184,235 22,184,235 22,163,650
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 2,082,887 1,368,057 1,371,879 1,367,040 1,366,203 1,363,303 1,363,753 1,362,840 1,361,657 1,236,934 1,359,511 1,358,395 864,391 599,389 24,552,543 22,188,918 22,186,993 532,016 22,177,423 21,745,403
Weighted Avg Shares Basic 2,082,887 1,368,057 1,367,192 1,367,040 1,366,060 1,363,303 1,363,753 1,362,840 1,361,657 1,236,934 1,359,511 1,358,395 864,391 599,389 24,552,543 22,188,918 22,186,993 532,016 22,177,423 21,745,403
Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input Value Source concept Filing period Confidence Provenance
Current Assets 5,169,000USD us-gaap:AssetsCurrent 2026-03-31 1.00 sec/companyfacts/cik=0001469443/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001469443\companyfacts.json
Total Liabilities 2,438,000USD us-gaap:Liabilities 2026-03-31 1.00 sec/companyfacts/cik=0001469443/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001469443\companyfacts.json
Cash 954,000USD us-gaap:CashAndCashEquivalentsAtCarryingValue 2026-03-31 1.00 sec/companyfacts/cik=0001469443/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001469443\companyfacts.json
Shares Outstanding 2,056,884 us-gaap:CommonStockSharesOutstanding 2026-03-31 1.00 sec/companyfacts/cik=0001469443/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001469443\companyfacts.json
NCAV 2,731,000USD derived 2026-03-31 n/a company-evidence-v1 | total_current_assets - total_liabilities
NCAV per share 1.33USD derived 2026-03-31 n/a company-evidence-v1 | NCAV / shares_outstanding
Margin of Safety 44.8% derived 2026-03-31 n/a gnni_publication_pack | internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding

Source Provenance

Data Source
Data Vault
Data Vault Root
D:\Projects\The Data Vault
CIK
0001469443
Company ID
n/a
Selected Annual Source
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001469443\companyfacts.json
Selected Quarterly Source
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001469443\companyfacts.json
Statement Extractor
companyfacts-screener-v1
View Extractor
companyfacts-screener-v1
Source Accession Count
26
Imported At
2026-07-04T23:04:37+00:00
Rendered At
2026-07-05T09:06:29+00:00

Run Audit

Mary Run
1ec055d81d1a42a39490a83bb9e1f22f
Mary As Of
2026-07-03
Accession
0001193125-26-223990
CIK
0001469443
Mary Filing Date
2026-05-14
Filing Currency
USD
Internal Discount
44.8%
Source State
Verified
Market Context
Not Displayed
Market Policy
internal_only_not_redistributed
Share Trend
Not Evaluated
Dilution
Needs Review

mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-05-14; mary_accession=0001193125-26-223990; mary_cik=0001469443; gnni_supporting_filing_date=2026-05-14; internal_discount=0.447933; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Archive